UK markets close in 7 hours 6 minutes

Silence Therapeutics plc (SLNCF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
7.090.00 (0.00%)
At close: 03:06PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 654.08M
Enterprise value 553.25M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)42.42
Price/book (mrq)30.27
Enterprise value/revenue 48.76
Enterprise value/EBITDA -11.70

Trading information

Stock price history

Beta (5Y monthly) 1.07
52-week change 3-11.71%
S&P500 52-week change 315.03%
52-week high 39.25
52-week low 36.39
50-day moving average 37.24
200-day moving average 37.79

Share statistics

Avg vol (3-month) 3337
Avg vol (10-day) 3390
Shares outstanding 589.78M
Implied shares outstanding 6N/A
Float 835.21M
% held by insiders 156.74%
% held by institutions 127.76%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021


Profit margin 0.00%
Operating margin (ttm)-368.17%

Management effectiveness

Return on assets (ttm)-29.22%
Return on equity (ttm)-333.73%

Income statement

Revenue (ttm)11.35M
Revenue per share (ttm)0.13
Quarterly revenue growth (yoy)58.80%
Gross profit (ttm)1.72M
EBITDA -41.41M
Net income avi to common (ttm)-42.42M
Diluted EPS (ttm)-0.66
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)76.47M
Total cash per share (mrq)0.85
Total debt (mrq)131k
Total debt/equity (mrq)0.80
Current ratio (mrq)4.52
Book value per share (mrq)0.18

Cash flow statement

Operating cash flow (ttm)3.6M
Levered free cash flow (ttm)3.27M